TABLE 2.
Correlation analysis of absolute choline and citrate tissue levels to the CSC/C signal ratio in tumor and benign regions in all patients (P1‐P8)
Patient | Tumor | Benign | ||
---|---|---|---|---|
Pearson correlation coefficient | Spearman correlation coefficient | Pearson correlation coefficient | Spearman correlation coefficient | |
Cho to CSC/C | Cit to CSC/C | Cho to CSC/C | Cit to CSC/C | |
P1 | 0.78 | −0.56 | 0.21 | −0.59 |
P2 | 0.74 | −0.61 | 0.23 | −0.6 |
P3 | 0.77 | −0.46 | 0.29 | −0.54 |
P4 | 0.79 | −0.67 | 0.2 | −0.47 |
P5 | 0.94 | −0.63 | 0.27 | −0.58 |
P6 | 0.65 | −0.48 | 0.22 | −0.61 |
P7 | 0.76 | −0.51 | 0.16 | −0.56 |
P8 | 0.81 | −0.61 | 0.11 | −0.57 |
Mean ± SD | 0.78 ± 0.1 | −0.57 ± 0.08 | 0.21 ± 0.06 | −0.57 ± 0.05 |
Pearson correlation coefficients and Spearman’s rank correlation coefficients are calculated for choline (Cho) to CSC/C and citrate (Cit) to CSC/C ratio, respectively.